Works by Kyung Hae Jung


Results: 97
    1
    2
    3
    4

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    5
    6

    Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 123, doi. 10.4143/crt.2021.1561
    By:
    • Jieun Lee;
    • Keun Seok Lee;
    • Sung Hoon Sim;
    • Heejung Chae;
    • Joohyuk Sohn;
    • Gun Min Kim;
    • Kyung-Hee Lee;
    • Su Hwan Kang;
    • Kyung Hae Jung;
    • Jae-ho Jeong;
    • Jae Ho Byun;
    • Su-Jin Koh;
    • Kyoung Eun Lee;
    • Seungtaek Lim;
    • Hee Jun Kim;
    • Hye Sung Won;
    • Hyung Soon Park;
    • Guk Jin Lee;
    • Soojung Hong;
    • Sun Kyung Baek
    Publication type:
    Article
    7
    8
    9
    10
    11

    Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 1, p. 43, doi. 10.4143/crt.2017.562
    By:
    • In Hae Park;
    • Seock-Ah Im;
    • Kyung Hae Jung;
    • Joo Hyuk Sohn;
    • Yeon Hee Park;
    • Keun Seok Lee;
    • Sung Hoon Sim;
    • Kyong-Hwa Park;
    • Jee Hyun Kim;
    • Byung Ho Nam;
    • Hee-Jun Kim;
    • Tae-Yong Kim;
    • Kyung-Hun Lee;
    • Sung-Bae Kim;
    • Jin-Hee Ahn;
    • Suee Lee;
    • Jungsil Ro
    Publication type:
    Article
    12
    13

    Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 2, p. 423, doi. 10.4143/crt.2016.191
    By:
    • Yeon Hee Park;
    • Tae Yong Kim;
    • Young-Hyuck Im;
    • Keun-Seok Lee;
    • In Hae Park;
    • Joohyuk Sohn;
    • Soo-Hyeon Lee;
    • Seock-Ah Im;
    • Jee Hyun Kim;
    • Se Hyun Kim;
    • Soo Jung Lee;
    • Su-Jin Koh;
    • Ki Hyeong Lee;
    • Yoon Ji Choi;
    • Eun Kyung Cho;
    • Suee Lee;
    • Seok Yun Kang;
    • Jae Hong Seo;
    • Sung-Bae Kim;
    • Kyung Hae Jung
    Publication type:
    Article
    14

    Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1373, doi. 10.4143/crt.2015.475
    By:
    • Se Hyun Kim;
    • Kyung Hae Jung;
    • Tae-Yong Kim;
    • Seock-Ah Im;
    • In Sil Choi;
    • Yee Soo Chae;
    • Sun Kyung Baek;
    • Seok Yun Kang;
    • Sarah Park;
    • In Hae Park;
    • Keun Seok Lee;
    • Yoon Ji Choi;
    • Soohyeon Lee;
    • Joo Hyuk Sohn;
    • Yeon-Hee Park;
    • Young-Hyuck Im;
    • Jin-Hee Ahn;
    • Sung-Bae Kim;
    • Jee Hyun Kim
    Publication type:
    Article
    15
    16
    17

    Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

    Published in:
    2022
    By:
    • Koh, Su-Jin;
    • Ohsumi, Shozo;
    • Takahashi, Masato;
    • Fukuma, Eisuke;
    • Jung, Kyung Hae;
    • Ishida, Takanori;
    • Dai, Ming-Shen;
    • Chang, Chuan-Hsun;
    • Dalvi, Tapashi;
    • Walker, Graham;
    • Bennett, James;
    • O'Shaughnessy, Joyce;
    • Balmaña, Judith
    Publication type:
    Correction Notice
    18

    Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 1, p. 92, doi. 10.1007/s12282-021-01283-4
    By:
    • Koh, Su-Jin;
    • Ohsumi, Shozo;
    • Takahashi, Masato;
    • Fukuma, Eisuke;
    • Jung, Kyung Hae;
    • Ishida, Takanori;
    • Dai, Ming-Shen;
    • Chang, Chuan-Hsun;
    • Dalvi, Tapashi;
    • Walker, Graham;
    • Bennett, James;
    • O'Shaughnessy, Joyce;
    • Balmaña, Judith
    Publication type:
    Article
    19
    20
    21

    A Randomized Feasibility Study of <sup>18</sup>F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, n. 4, p. 563, doi. 10.2967/jnumed.116.178368
    By:
    • Sun Young Chae;
    • Sung-Bae Kim;
    • Sei Hyun Ahn;
    • Hye Ok Kim;
    • Dok Hyun Yoon;
    • Jin-Hee Ahn;
    • Kyung Hae Jung;
    • Sangwon Han;
    • Seung Jun Oh;
    • Sang Ju Lee;
    • Hee Jeong Kim;
    • Byung Ho Son;
    • Gyungyub Gong;
    • Hyo Sang Lee;
    • Dae Hyuk Moon
    Publication type:
    Article
    22
    23

    Cytotoxic effects of pemetrexed in gastric cancer cells.

    Published in:
    Cancer Science, 2005, v. 96, n. 6, p. 365, doi. 10.1111/j.1349-7006.2005.00058.x
    By:
    • Jee Hyun Kim;
    • Keun-Wook Lee;
    • Yeonjoo Jung;
    • Tai Young Kim;
    • Hye Seon Ham;
    • Hyun-Soon Jong;
    • Kyung Hae Jung;
    • Seock-Ah Im;
    • Tae-You Kim;
    • Noe Kyeong Kim;
    • Yung-Jue Bang
    Publication type:
    Article
    24

    Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trial.

    Published in:
    2020
    By:
    • Yun, Young Ho;
    • Lim, Cheol Il;
    • Lee, Eun Sook;
    • Kim, Young Tae;
    • Shin, Kyung Hwan;
    • Kim, Young‐Woo;
    • Park, Kyu Joo;
    • Jeong, Seung‐Yong;
    • Ryu, Keun Won;
    • Han, Wonshik;
    • Jung, Kyung Hae;
    • Park, Sung Chan;
    • Kim, Moon Soo;
    • Kim, Sung;
    • Shim, Young Mog;
    • Oh, Jae Hwan;
    • Lee, Jong Mog;
    • Ryoo, Seung‐Bum;
    • Woo, Joohyun;
    • Noh, Dong‐Young
    Publication type:
    journal article
    25
    26
    27

    Genomic landscape of extraordinary responses in metastatic breast cancer.

    Published in:
    Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-01973-x
    By:
    • Lim, Sun Min;
    • Kim, Eunyoung;
    • Jung, Kyung Hae;
    • Kim, Sora;
    • Koo, Ja Seung;
    • Kim, Seung Il;
    • Park, Seho;
    • Park, Hyung Seok;
    • Park, Byoung Woo;
    • Cho, Young Up;
    • Kim, Ji Ye;
    • Paik, Soonmyung;
    • Kwon, Nak-Jung;
    • Kim, Gun Min;
    • Kim, Ji Hyoung;
    • Kim, Min Hwan;
    • Jeon, Min Kyung;
    • Kim, Sangwoo;
    • Sohn, Joohyuk
    Publication type:
    Article
    28
    29
    30

    Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-70887-5
    By:
    • Yoo, Tae-Kyung Robyn;
    • Lee, Ji-Young;
    • Park, Hwan;
    • Cho, Whi-Kyung;
    • Jeon, Seyeon;
    • Jun, Ha Ra;
    • Lee, Sae Byul;
    • Chung, Il Yong;
    • Kim, Hee Jeong;
    • Ko, Beom Seok;
    • Lee, Jong Won;
    • Son, Byung Ho;
    • Ahn, Sei-Hyun;
    • Jeong, Jae Ho;
    • Kim, Jeong Eun;
    • Ahn, Jin-Hee;
    • Jung, Kyung Hae;
    • Kim, Sung-Bae;
    • Lee, Hee Jin;
    • Gong, Gyungyub
    Publication type:
    Article
    31

    Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.

    Published in:
    Advances in Therapy, 2025, v. 42, n. 5, p. 2015, doi. 10.1007/s12325-024-03080-9
    By:
    • Oaknin, Ana;
    • Lee, Jung-Yun;
    • Makker, Vicky;
    • Oh, Do-Youn;
    • Banerjee, Susana;
    • González-Martín, Antonio;
    • Jung, Kyung Hae;
    • Ługowska, Iwona;
    • Manso, Luis;
    • Manzano, Aránzazu;
    • Melichar, Bohuslav;
    • Siena, Salvatore;
    • Stroyakovskiy, Daniil;
    • Fielding, Anitra;
    • Puvvada, Soham;
    • Smith, Ann;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    32

    Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 11, p. 4125, doi. 10.1007/s12325-024-02975-x
    By:
    • Oaknin, Ana;
    • Lee, Jung-Yun;
    • Makker, Vicky;
    • Oh, Do-Youn;
    • Banerjee, Susana;
    • González-Martín, Antonio;
    • Jung, Kyung Hae;
    • Ługowska, Iwona;
    • Manso, Luis;
    • Manzano, Aránzazu;
    • Melichar, Bohuslav;
    • Siena, Salvatore;
    • Stroyakovskiy, Daniil;
    • Fielding, Anitra;
    • Puvvada, Soham;
    • Smith, Ann;
    • Meric-Bernstam, Funda
    Publication type:
    Article
    33
    34

    The association of self-leadership, health behaviors, and posttraumatic growth with health-related quality of life in patients with cancer.

    Published in:
    Psycho-Oncology, 2014, v. 23, n. 12, p. 1423, doi. 10.1002/pon.3582
    By:
    • Yun, Young Ho;
    • Sim, Jin Ah;
    • Jung, Ju Youn;
    • Noh, Dong‐Young;
    • Lee, Eun Sook;
    • Kim, Young Woo;
    • Oh, Jae Hwan;
    • Ro, Jung Sil;
    • Park, Sang Yoon;
    • Park, Sang Jae;
    • Cho, Kwan Ho;
    • Chang, Yoon Jung;
    • Bae, Yeon Min;
    • Kim, Si Young;
    • Jung, Kyung Hae;
    • Zo, Zae Ill;
    • Lim, Jae‐Young;
    • Lee, Soon Nam
    Publication type:
    Article
    35

    Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers.

    Published in:
    2016
    By:
    • Park, Ji;
    • Kang, Myung;
    • Ahn, Jin-Hee;
    • Kim, Jeong;
    • Jung, Kyung;
    • Gong, Gyungyub;
    • Lee, Hee;
    • Son, Byung-Ho;
    • Ahn, Sei-Hyun;
    • Kim, Hak-Hee;
    • Shin, Hee;
    • Moon, Dae-Hyuk;
    • Kim, Sung-Bae;
    • Park, Ji Hyun;
    • Kang, Myung Joo;
    • Kim, Jeong Eun;
    • Jung, Kyung Hae;
    • Lee, Hee Jin;
    • Shin, Hee Jung
    Publication type:
    journal article
    36
    37
    38

    Predictive and prognostic value of <sup>18</sup>F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2096, doi. 10.1007/s00259-024-07058-1
    By:
    • Jeong, Hyehyun;
    • Ryu, Jeongryul;
    • Jeong, Jae Ho;
    • Han, Sangwon;
    • Hyung, Jaewon;
    • Ahn, Jin-Hee;
    • Jung, Kyung Hae;
    • Kim, Sung-Bae;
    • Jeong, Byung-Kwan;
    • Lee, Hee Jin;
    • Gong, Gyungyub;
    • Moon, Dae Hyuk
    Publication type:
    Article
    39

    Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 9, p. 1036, doi. 10.1093/jnci/djad080
    By:
    • Kim, Min Hwan;
    • Kim, Gun Min;
    • Ahn, Jin Mo;
    • Ryu, Won-Ji;
    • Kim, Seul-Gi;
    • Kim, Jee Hung;
    • Kim, Tae Yeong;
    • Han, Hyun Ju;
    • Kim, Jee Ye;
    • Park, Hyung Seok;
    • Park, Seho;
    • Park, Byeong Woo;
    • Kim, Seung Il;
    • Jeong, Joon;
    • Lee, Jieun;
    • Paik, Soonmyung;
    • Kim, Sangwoo;
    • Jung, Kyung Hae;
    • Cho, Eun Hae;
    • Sohn, Joohyuk
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10).

    Published in:
    Cancers, 2020, v. 12, n. 11, p. 3265, doi. 10.3390/cancers12113265
    By:
    • Lee, Soohyeon;
    • Im, Seock-Ah;
    • Kim, Gun Min;
    • Jung, Kyung Hae;
    • Kang, Seok Yun;
    • Park, In Hae;
    • Kim, Jee Hyun;
    • Lee, Kyoung Eun;
    • Ahn, Hee Kyung;
    • Lee, Moon Hee;
    • Kim, Hee-Jun;
    • Kim, Han Jo;
    • Lee, Jong In;
    • Koh, Su-Jin;
    • Park, Yeon Hee
    Publication type:
    Article
    50